MPWM Advisory Solutions’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.21K Hold
20
﹤0.01% 530
2025
Q4
$1.08K Hold
20
﹤0.01% 507
2025
Q3
$902 Buy
+20
New +$934 ﹤0.01% 487
2025
Q2
Sell
-44
Closed -$2.68K 559
2025
Q1
$2.68K Hold
44
﹤0.01% 429
2024
Q4
$2.49K Buy
+44
New +$2.46K ﹤0.01% 448

Other funds holding BMY

MPWM Advisory Solutions's BMY Position: Q1 2026 in Review

MPWM Advisory Solutions held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 20 shares worth $1.21K. The position accounts for ﹤0.01% of the portfolio, ranked #530.

MPWM Advisory Solutions first reported a position in BMY in Q4 2024 and has held it in 5 quarters since. The position peaked at $2.68K in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • MPWM Advisory Solutions held 20 shares of Bristol-Myers Squibb worth $1.21K as of Q1 2026.
  • MPWM Advisory Solutions left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of MPWM Advisory Solutions's portfolio in Q1 2026, its #530 holding.
  • MPWM Advisory Solutions first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 5 quarters since.
  • MPWM Advisory Solutions's Bristol-Myers Squibb position peaked at $2.68K in Q1 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on MPWM Advisory Solutions's 13F filing for Q1 2026, filed 13 May 2026.